Global trends in research of macrophages associated with acute lung injury over past 10 years: a bibliometric analysis

S Wang, H Zhou, L Zheng, W Zhu, L Zhu… - Frontiers in …, 2021 - frontiersin.org
Acute lung injury (ALI) is an intractable disorder associated with macrophages. This
bibliometric analysis was applied to identify the characteristics of global scientific output, the …

[HTML][HTML] Interleukin-6 in SARS-CoV-2 induced disease: Interactions and therapeutic applications

J Majidpoor, K Mortezaee - Biomedicine & Pharmacotherapy, 2022 - Elsevier
Abstract Interleukin-6 (IL-6) is a multi-tasking cytokine that represents high activity in patients
with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and cancer. High …

SARS-CoV-2 infection and lung regeneration

F Zhao, Q Ma, Q Yue, H Chen - Clinical microbiology reviews, 2022 - Am Soc Microbiol
The lung is the primary site of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2)-induced immunopathology whereby the virus enters the host cells by binding to …

Interstitial pneumonia and diffuse alveolar damage in domestic animals

FR Carvallo, VB Stevenson - Veterinary Pathology, 2022 - journals.sagepub.com
Classification of pneumonia in animals has been controversial, and the most problematic
pattern is interstitial pneumonia. This is true from the gross and histologic perspectives, and …

Current strategies in treating cytokine release syndrome triggered by coronavirus SARS-CoV-2

LG Wang, L Wang - ImmunoTargets and Therapy, 2022 - Taylor & Francis
Since the beginning of the SARS-CoV-2 pandemic, the treatments and management of the
deadly COVID-19 disease have made great progress. The strategies for developing novel …

Repurposing clinically available drugs and therapies for pathogenic targets to combat SARS‐CoV‐2

Y Xue, H Mei, Y Chen, JD Griffin, Q Liu… - MedComm, 2023 - Wiley Online Library
Abstract The coronavirus disease 2019 (COVID‐19) pandemic has affected a large portion
of the global population, both physically and mentally. Current evidence suggests that the …

Efficacy of thymosin-α-1 in patients with COVID-19: A systematic review and meta-analysis

P Wang, C Wang, D Chen - European Journal of …, 2023 - journals.sagepub.com
Objective To identify whether thymosin-α-1 (Tα1) is effective in patients with Coronavirus
disease 2019 (COVID-19) and to determine a suitable population for Tα1 treatment …

[HTML][HTML] Adjunctive viral cell culture supports treatment decision‐making in patients with secondary humoral immunodeficiency and persistent SARS‐CoV‐2 infection

SJC Pallett, R Wake, J Youngs, C Pope… - British Journal of …, 2022 - ncbi.nlm.nih.gov
Discussion Determining SARS-CoV-2 viability in patients with haematological malignancy
has implications for treatment-based decision-making. For example, B-cell depletion with …

Delayed COVID‐19‐induced cytokine storm after root canal therapy with favorable response to plasmapheresis, tocilizumab, and methylprednisolone pulses therapy …

F Aghaeimeybodi, MM Derakhshan Barjoei… - Clinical Case …, 2022 - Wiley Online Library
COVID‐19 showed different characteristics, and many cases showed clinical manifestations
that could not be attributed to other conditions. We present a 22‐year‐old woman who had …

VAI TRÒ QUAN TRỌNG CỦA INTERLEUKIN 6 TRONG COVID-19

TTT Nga, NT Quang, NTT Trang… - Tạp chí Y Dược học …, 2023 - tapchi.ctump.edu.vn
Tóm tắt Vi rút corona gây hội chứng suy hô hấp cấp tính SARS‐CoV‐2, đã xuất hiện vào
tháng 12 năm 2019 tại Vũ Hán, Trung Quốc. Vi rút SAR-CoV-2 có thể kích hoạt các phản …